• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Creavo Medical raises $15m

Creavo Medical raises $15m

July 6, 2017 By Fink Densford

CreavoMedical tech spin-out Creavo Medical Technologies said this week it raised $15.3 million (EU €13.4 million) in equity funding to help support its magnetocardiography diagnostic tech designed to measure, display and store electromagnetic fluctuations caused by heart activity.

The round was led by IP Group and joined by existing investors the University of Leeds and newly invested Parkwalk Advisors and Puhua Capital, the UK-based company said.

“We have supported Creavo from the very beginning and have been impressed with its substantial growth and ambition. I am particularly excited about this next chapter in Creavo’s evolution which will see its technology launched commercially for the benefit of patients and providers in the emergency room, a setting which continues to dominate the news and is an enormous challenge globally. Creavo is well-positioned to disrupt multiple healthcare markets to benefit both patients and payors, and we are excited to have led this funding round in Creavo,” IP Group healthcare director Simon Graindorge said in a prepared statement.

Creavo said it is currently engaged in a UK-based multicenter clinical study exploring the efficiency of its application, which is designed to help physicians quickly rule out serious heart related problems upon admission to emergency departments.

The company said the core technological platform has a potential range of applications outside emergency detection and could be used to predict arrhythmias and as diagnostics for other organs.

“To have attracted such highly respected companies such as Parkwalk Advisors and Puhua Capital Ltd is a strong endorsement of Creavo’s strategy, team and its state of the art medical technology. The funding will be used to continue growing the Creavo business and move towards a full commercial launch in Europe. We will conclude our clinical study in the UK, build our US operation and associated clinical study and conduct further research to expand the use of our technology into other applications. It will also enable us to develop a fully commercial device encompassing all of the learnings from the initial clinical studies. We are delighted that there has been such strong support and endorsement of Creavo’s strategy and team,” Creavo chair Robert Barr said in a press release.

Filed Under: Business/Financial News, Cardiovascular Tagged With: creavomedical

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy